Term ends Oct 31, 2041 · High confidence
20-year base term ends Apr 12, 2039
Held by Verily Life Sciences LLC
Filed Apr 12, 2019 as application 16/383,337 · Granted Jun 20, 2023
Base term plus 933 days of patent term adjustment (USPTO delay)
Today
2019
2041
Clock starts
Apr 12, 2019
Apr 12, 2019
Term ends
Oct 31, 2041
Oct 31, 2041
Granted
Jun 20, 2023
Jun 20, 2023
base term
patent term adjustment
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
933
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 933 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 12, 2019, when this application, 16/383,337, was filed | Apr 12, 2039 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +933 days, USPTO patent term adjustment record | Oct 31, 2041 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 31, 2041 | High confidence |
This family
| US 10,575,390 | In force May 2038 | May 2038 |
| US 11,679,036 | this patent Oct 2041 | Oct 2041 |
| Application PCT/US2019/030684 | PCT application no patent term | no patent term |
| US 10,880,972 | In force May 2038 | May 2038 |
| US 11,275,023 | In force May 2038 | May 2038 |
| US 12,458,543 | In force Apr 2039 | Apr 2039 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 16, 2019 Reel 49204, frame 870 | Schiffer, Brian; Parlikar, Tushar; Guilardi, Brian Ward | Verily Life Sciences LLC | Assignment of Assignor's Interest |
| Nov 19, 2024 Reel 69390, frame 656 | Verily Life Sciences LLC | Verily Life Sciences LLC | Change of Address |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2041
Term ends Oct 31, 2041. Maintenance fees still fall due before then
Note
The 933 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
6
later US patents cite this one
That is top 25% of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.